UMIN ID: UMIN000054083
Registered date:07/06/2024
Investigation of preference, clinical efficacy and trough concentration of vedolizumab by patient-oriented switching to intravenous (IV) or subcutaneous (SC) injection in patients with ulcerative colitis
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | ulcerative colitis |
| Date of first enrollment | 2024/06/07 |
| Target sample size | 50 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Selectivity of intraveous or subctaneous injection of vedolizumab |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1. Patients who has allergy to vedolizumab 2. Patients who determined to be inappropriate for this study by physician |
Related Information
| Primary Sponsor | Saitama Medical Center, Saitama Medical University |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Saitama Medical Center, Saitama Medical University |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Shingo Kato |
| Address | 1981, Kamoda, Kawagoe City, Saitama, Japan Japan 3508550 |
| Telephone | 0492283564 |
| skato@saitama-med.ac.jp | |
| Affiliation | Saitama Medical Center, Saitama Medical University Department of Gastroenterology and Hepatology |
| scientific contact | |
| Name | Shingo Kato |
| Address | 1981, Kamoda, Kawagoe City, Saitama, Japan Japan |
| Telephone | 0492283564 |
| skato@saitama-med.ac.jp | |
| Affiliation | Saitama Medical Center, Saitama Medical University Department of Gastroenterology and Hepatology |